Key Takeaways
- Sector: Technology, Software & Gaming, Healthcare, Healthtech & Medtech.
- Geography: United States, Global.
Analysis
Venture capital firm Norwest has announced the closure of its latest fund, NVP XII, amassing a substantial $1.2 billion. This significant capital infusion is earmarked for early to late-stage venture and growth equity investments, signaling a robust commitment to backing innovative companies across diverse technology and healthcare sectors. The firm's extensive history, spanning over five decades, positions it as a seasoned player ready to capitalize on emerging technological advancements and market opportunities.
The technology sector continues to be a primary focus, recognized by Norwest as a critical engine for global economic expansion and job creation. The firm highlights significant ongoing innovation in areas such as cloud computing and Software-as-a-Service (SaaS), the pervasive influence of mobile technology, the rapid expansion of online marketplaces, and advancements in cybersecurity. These trends collectively present a fertile ground for investment, with Norwest aiming to deploy its new fund to support companies driving these transformations.
NVP XII will build upon Norwest's established track record, which saw over 11 portfolio companies achieve liquidity events in the preceding year. Notable successes include the highly anticipated initial public offering of cybersecurity firm FireEye, the public debut of digital coupon platform RetailMeNot, and strategic acquisitions such as Virtela by NTT Communications and ScaleIO by EMC. These exits underscore Norwest's ability to identify and nurture high-potential ventures through to successful market realization.
With a strategic emphasis on a multi-sector, multi-stage, and global investment approach, Norwest leverages a collaborative team structure. The firm boasts a dedicated team of over 42 investment professionals and a total staff of 85 worldwide, with plans for further expansion. This collective expertise is made available to portfolio companies, offering comprehensive support to foster growth and operational excellence. The firm also recently revitalized its healthcare practice, contributing 17 growth and venture investments in that domain.
The firm's commitment extends beyond capital, focusing on partnering with visionary entrepreneurs. Norwest emphasizes its role in helping founders harness technology to build enduring businesses with lasting value. This philosophy is supported by a dedicated portfolio success team that assists companies with talent acquisition, go-to-market strategies, product development, and corporate development. The firm's growth trajectory is further evidenced by its milestone of surpassing 550 portfolio company investments and contributing to the creation of over 100,000 jobs over its operational history.
The announcement of NVP XII arrives at a time when the venture capital market is experiencing dynamic shifts. While specific market data for the current fundraising environment is fluid, the ability of a firm like Norwest to secure such a significant fund indicates sustained investor confidence in established managers and the venture asset class, particularly within technology and healthcare. This capital will enable Norwest to continue its mission of identifying and scaling disruptive innovations, contributing to the ongoing evolution of the global economy.